Coliform bacteria and E. coli in pharma water systems: A hidden threat to product integrity Read more
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a Section 232 investigation Read more
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease treatment Read more